Get access

Effects of fatty acids on cardioprotection by pre-ischaemic inhibition of the malate–aspartate shuttle

Authors

  • Christian Dalgas,

    Corresponding author
    1. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    • Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    Search for more papers by this author
  • Jonas Agerlund Povlsen,

    1. Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    2. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    Search for more papers by this author
  • Bo Løfgren,

    1. Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    2. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    Search for more papers by this author
  • Sune Brinck Erichsen,

    1. Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    2. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    Search for more papers by this author
  • Hans Erik Bøtker

    1. Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    2. Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark
    Search for more papers by this author

Correspondence: Dr Christian Dalgas, Department of Cardiology, Aarhus University Hospital Skejby, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark. Email: christiandalgas@hotmail.com

Summary

  1. The malate–aspartate shuttle (MAS) is the main pathway for balancing extra- and intramitochondrial glucose metabolism. Pre-ischaemic shutdown of the MAS by aminooxyacetate (AOA) mimics ischaemic preconditioning (IPC) in rat glucose-perfused hearts. The aim of the present study was to determine the effects of fatty acids (FA) on cardioprotection by pre-ischaemic inhibition of the MAS.
  2. Isolated rat hearts were divided into four groups (control; pre-ischaemic AOA (0.2 mmol/L); IPC; and AOA + IPC) and were perfused with 11 mmol/L glucose, 3% bovine serum albumin plus 0, 0.4 or 1.2 mmol/L FA. The perfusion protocol included 30 min global no-flow ischaemia and 120 min reperfusion. Infarct size (IS), haemodynamic recovery, glucose oxidation and lactate release were evaluated in all four groups.
  3. Pre-ischaemic AOA reduced the IS of the left ventricle in hearts perfused with 0, 0.4 and 1.2 mmol/L FA compared with that in control hearts (26 ± 2% vs 53 ± 4%, 29 ± 3% vs 53 ± 4% and 61 ± 4% vs 81 ± 3%, respectively; P < 0.01 for all). After 2 h reperfusion, AOA improved haemodynamic recovery in the absence (52 ± 2 vs 27 ± 3 mmHg in the AOA and control groups, respectively; P < 0.001) but not in the presence, of FA. Both IPC and AOA + IPC reduced IS and improved haemodynamic recovery regardless of FA levels. Postischaemic glucose oxidation was suppressed by FA and did not differ significantly between the different groups.
  4. In conclusion, the reduction in IS induced by pre-ischaemic MAS shutdown is not compromised by physiological FA concentrations. Transient MAS shutdown may be involved in IPC, but is not sufficient on its own as the underlying mechanism for IPC.
Get access to the full text of this article

Ancillary